Trials / Completed
CompletedNCT04409249
Prognosis in Pregnant With COVID-19
Prognostic Factors in Pregnant Women With COVID-19
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 155 (actual)
- Sponsor
- Kanuni Sultan Suleyman Training and Research Hospital · Academic / Other
- Sex
- Female
- Age
- 18 Years – 45 Years
- Healthy volunteers
- —
Summary
COVID-19 is a disease whose development, prognosis mechanism and immune status are still unknown. The aim of the study is to determine the relationship between clinical and laboratory data and the severity of the disease by evaluating the hematological and radiological features of the patients. The secondary aim is to determine the predictive values of clinical and laboratory data for the severity of COVID-19.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | imaging, blood tests | PCR and CT results, hemogram, urea, creatinine, AST, ALT, LDH, D-Dimer, ferritin, lipase, amylase, CRP, procalcitonin, albumin, total protein, coagulation tests-PT, APTT, Fibrinogen-, Troponin T, CK , electrolytes, blood gas, bilirubins |
Timeline
- Start date
- 2020-03-15
- Primary completion
- 2020-05-25
- Completion
- 2020-05-28
- First posted
- 2020-06-01
- Last updated
- 2020-07-02
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT04409249. Inclusion in this directory is not an endorsement.